On the recordSeptember 3, 1996
Mr. President, the Center for Molecular Medicine and Immunology [CMMI], located in Newark, NJ, has been a leader in developing life saving treatment for cancers that plague our Nation's veteran population. In particular, CMMI is conducting research into radioimmunodetection and radio- immunotherapy, a new technology that uses radioisotopes and monochlonal antibodies to target tumors often too small for detection with traditional equipment and delivers cancer fighting therapy to targeted muscle tissue and organs with virtually no side effects. This has the potential to be very helpful to treating our Nation's veterans, many of whom suffer from cancer. Mr. President, the House report on the fiscal year 1997 VA-HUD appropriations bill included language that encourages the Veterans' Administration to enter into a partnership with nonprofit research centers to expand these research efforts.
Source
govinfo.gov




